<DOC>
	<DOC>NCT01239251</DOC>
	<brief_summary>The purpose of this study is to test the ease of using a new device, called the GlowCap that reminds the patient to take their breast cancer hormone pill. The study will collect information about the experience with this device and what the patient thinks of its role in the daily pill taking routine.</brief_summary>
	<brief_title>GlowCap Reminder System in Patients With Early Stage Breast Cancer Receiving Adjuvant Endocrine Therapy</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Early stage breast cancer patients taking adjuvant endocrine therapy (ie, tamoxifen, anastrozole, letrozole, exemestane). Age â‰¥ 60 years Must have broadband internet access at home (to enable the base for the system to communicate to the Vitality server). Must have a landline or mobile phone NonEnglish speaking patients</criteria>
	<gender>Female</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>GlowCap</keyword>
	<keyword>adjuvant endocrine therapy</keyword>
</DOC>